DK2470187T3 - Nødintervention med aktivt kul ved dabigatranetexilatoverdosering - Google Patents
Nødintervention med aktivt kul ved dabigatranetexilatoverdoseringInfo
- Publication number
- DK2470187T3 DK2470187T3 DK10747022.1T DK10747022T DK2470187T3 DK 2470187 T3 DK2470187 T3 DK 2470187T3 DK 10747022 T DK10747022 T DK 10747022T DK 2470187 T3 DK2470187 T3 DK 2470187T3
- Authority
- DK
- Denmark
- Prior art keywords
- emergency
- dabigatran
- ethylate
- overdose
- coal
- Prior art date
Links
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 title 1
- 239000003245 coal Substances 0.000 title 1
- YBSJFWOBGCMAKL-UHFFFAOYSA-N dabigatran Chemical compound N=1C2=CC(C(=O)N(CCC(O)=O)C=3N=CC=CC=3)=CC=C2N(C)C=1CNC1=CC=C(C(N)=N)C=C1 YBSJFWOBGCMAKL-UHFFFAOYSA-N 0.000 title 1
- 229960003850 dabigatran Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23632109P | 2009-08-24 | 2009-08-24 | |
| PCT/EP2010/062229 WO2011023653A1 (en) | 2009-08-24 | 2010-08-23 | Emergency interventions of active charcoal with dabigatran etexilate overdosing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2470187T3 true DK2470187T3 (da) | 2013-10-28 |
Family
ID=42740360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10747022.1T DK2470187T3 (da) | 2009-08-24 | 2010-08-23 | Nødintervention med aktivt kul ved dabigatranetexilatoverdosering |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US20110206656A1 (da) |
| EP (1) | EP2470187B1 (da) |
| JP (1) | JP2013502449A (da) |
| KR (1) | KR20120050457A (da) |
| CN (1) | CN102481317B (da) |
| AR (1) | AR077909A1 (da) |
| AU (1) | AU2010288601A1 (da) |
| BR (1) | BR112012004169A2 (da) |
| CA (1) | CA2767966A1 (da) |
| CL (1) | CL2012000488A1 (da) |
| DK (1) | DK2470187T3 (da) |
| EA (1) | EA201200319A1 (da) |
| ES (1) | ES2436076T3 (da) |
| IL (1) | IL216968A0 (da) |
| MX (1) | MX2012001767A (da) |
| NZ (1) | NZ597359A (da) |
| PH (1) | PH12012500388A1 (da) |
| PL (1) | PL2470187T3 (da) |
| TW (1) | TW201124143A (da) |
| WO (1) | WO2011023653A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI513466B (zh) | 2010-01-20 | 2015-12-21 | Boehringer Ingelheim Int | 抗凝血劑解毒劑 |
| EA201301090A1 (ru) * | 2011-03-30 | 2014-05-30 | Бёрингер Ингельхайм Интернациональ Гмбх | Антидоты антикоагулянтов |
| GB201120693D0 (en) * | 2011-12-01 | 2012-01-11 | Convatec Technologies Inc | Wound dressing for use in vacuum therapy |
| CN114452839B (zh) * | 2022-02-10 | 2023-04-21 | 中南大学湘雅医院 | 一种抗凝抗栓血液净化膜及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5277820A (en) * | 1992-02-06 | 1994-01-11 | Hemocleanse, Inc. | Device and method for extracorporeal blood treatment |
| PE121699A1 (es) | 1997-02-18 | 1999-12-08 | Boehringer Ingelheim Pharma | Heterociclos biciclicos disustituidos como inhibidores de la trombina |
| EP1485094B2 (de) | 2002-03-07 | 2020-03-25 | Boehringer Ingelheim International GmbH | Oral zu applizierende darreichungsform für 3- [(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] -propionsäure-ethylester oder dessen salze |
-
2010
- 2010-08-23 DK DK10747022.1T patent/DK2470187T3/da active
- 2010-08-23 MX MX2012001767A patent/MX2012001767A/es active IP Right Grant
- 2010-08-23 CA CA2767966A patent/CA2767966A1/en not_active Abandoned
- 2010-08-23 ES ES10747022T patent/ES2436076T3/es active Active
- 2010-08-23 EA EA201200319A patent/EA201200319A1/ru unknown
- 2010-08-23 WO PCT/EP2010/062229 patent/WO2011023653A1/en not_active Ceased
- 2010-08-23 BR BR112012004169A patent/BR112012004169A2/pt not_active IP Right Cessation
- 2010-08-23 PH PH1/2012/500388A patent/PH12012500388A1/en unknown
- 2010-08-23 KR KR1020127004779A patent/KR20120050457A/ko not_active Ceased
- 2010-08-23 EP EP10747022.1A patent/EP2470187B1/en active Active
- 2010-08-23 AR ARP100103077A patent/AR077909A1/es active IP Right Grant
- 2010-08-23 TW TW099128118A patent/TW201124143A/zh unknown
- 2010-08-23 NZ NZ597359A patent/NZ597359A/en not_active IP Right Cessation
- 2010-08-23 CN CN201080037665.XA patent/CN102481317B/zh not_active Expired - Fee Related
- 2010-08-23 JP JP2012526022A patent/JP2013502449A/ja active Pending
- 2010-08-23 AU AU2010288601A patent/AU2010288601A1/en not_active Abandoned
- 2010-08-23 PL PL10747022T patent/PL2470187T3/pl unknown
- 2010-08-24 US US12/862,110 patent/US20110206656A1/en not_active Abandoned
-
2011
- 2011-12-14 IL IL216968A patent/IL216968A0/en unknown
-
2012
- 2012-02-24 CL CL2012000488A patent/CL2012000488A1/es unknown
-
2013
- 2013-07-22 US US13/947,398 patent/US20130302311A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PL2470187T3 (pl) | 2014-01-31 |
| WO2011023653A1 (en) | 2011-03-03 |
| ES2436076T3 (es) | 2013-12-26 |
| MX2012001767A (es) | 2012-02-29 |
| EP2470187A1 (en) | 2012-07-04 |
| NZ597359A (en) | 2014-01-31 |
| TW201124143A (en) | 2011-07-16 |
| US20110206656A1 (en) | 2011-08-25 |
| IL216968A0 (en) | 2012-02-29 |
| EP2470187B1 (en) | 2013-08-21 |
| CN102481317A (zh) | 2012-05-30 |
| EA201200319A1 (ru) | 2012-09-28 |
| CL2012000488A1 (es) | 2012-08-31 |
| PH12012500388A1 (en) | 2012-10-22 |
| AU2010288601A1 (en) | 2012-02-02 |
| KR20120050457A (ko) | 2012-05-18 |
| US20130302311A1 (en) | 2013-11-14 |
| CN102481317B (zh) | 2014-09-03 |
| BR112012004169A2 (pt) | 2016-03-29 |
| AR077909A1 (es) | 2011-09-28 |
| JP2013502449A (ja) | 2013-01-24 |
| CA2767966A1 (en) | 2011-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2503013A4 (en) | HEAT-RESISTANT SUPER ALLOY | |
| BRPI1014776A2 (pt) | autenticação multicamada baseada em modelo | |
| BR112012001063A2 (pt) | intervenção poço abaixo | |
| EP2508513A4 (en) | 2-PYRIDONES COMPOUNDS | |
| FI20090273A0 (fi) | Hissi | |
| HUE039943T2 (hu) | Újraömlesztõ kemence | |
| EP2449173A4 (en) | refiner | |
| EP2378292A4 (en) | Autoanalyzer | |
| DK2391893T3 (da) | Lyofiliseret dabigatran | |
| DK2373644T3 (da) | Pyridazinonderivater | |
| DK2389166T3 (da) | Farmaceutisk sammensætning omfattende aleglitazar | |
| BRPI0913514A2 (pt) | regeneração pancreática induzida por periostina | |
| BR112013000369A2 (pt) | elemanto estrutural refratário | |
| IT1398939B1 (it) | Cerniera per mobili | |
| DK2070602T3 (da) | Partikelsepareringsanordning | |
| FI20096190A0 (fi) | Tutkimuslaite | |
| BR112012004169A2 (pt) | intervenções de emergência com carvão vegetal ativado em superdosagem de etexilato de dabigatran | |
| BRPI0910856A2 (pt) | pista sólida | |
| IT1391542B1 (it) | Cassaforte | |
| FI20095440A0 (fi) | Muodostusosa | |
| AT10432U2 (de) | Brennstoffzange | |
| DK2373647T3 (da) | Pyridazinonderivater | |
| ES1070413Y (es) | Forjado | |
| FI8597U1 (fi) | Pelastuskanto-väline | |
| FI20080291A0 (fi) | Hiilestin |